Executive Summary
On January 23, 2026, over 100 US SEC 8-K filings highlight a surge in merger/acquisition activity, particularly among SPACs and small-cap entities entering material definitive agreements, alongside pervasive executive turnover across sectors indicating potential leadership instability. Clusters of delistings and control changes in biotechs and micro-caps signal distress and going-private risks, while isolated insolvencies add to bearish pockets; overall neutral sentiment belies cumulative M&A consolidation themes with portfolio implications for liquidity and governance exposure. Institutional investors should prioritize SPAC watchlists for alpha while hedging small-cap biotech downside amid high materiality events.
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from January 21, 2026.
Investment Signals(5)
- GUESS INC (GES)↓(BEARISH)▲
Multi-event filing including delisting notice, control change, and acquisition completion signals major restructuring or going-private
Comprehensive merger indicators with delisting, control shift, and asset disposition point to acquisition exit [NEUTRAL-to-BEARISH]
- LightPath Technologies↓(BULLISH)▲
Completed acquisition (Item 2.01) amid material agreement suggests growth catalyst
- International Paper (IP)(BULLISH)▲
Asset disposition completion with Reg FD disclosure may unlock value
Cluster of delisting notices (Item 3.01) across biotechs flags micro-cap distress wave
Risk Flags(4)
- Biotech/Micro-cap Delistings▼
Multiple high-materiality notices (KALA BIO, REVIVA, Astria, Aprea, Nexalin, 60 Degrees) indicate listing failures and liquidity evaporation risks
- SPAC M&A Opacity▼
Dozens of acquisition corps (OneIM, ASPAC III, EGH, Quantumsphere, etc.) with undisclosed deal details heighten valuation and dilution uncertainties
- Executive Churn Epidemic▼
40+ Item 5.02 filings (Analog Devices, NVIDIA, Block, Lucid, etc.) across firms suggest governance instability and potential performance issues
- Undisclosed Material Agreements▼
Pervasive Item 1.01 filings without terms (LanzaTech, Axogen, NeoVolta) obscure balance sheet and strategic impacts
Opportunities(3)
- SPAC De-SPAC Pipeline◆
High volume of acquisition corp mergers (Trailblazer, Spring Valley, TLGY, Bleichroeder) offers merger arbitrage and post-deal alpha if pro formas supportive
- M&A Consolidation Plays◆
Completed deals (International Paper, LightPath, ETHZilla) and multi-item filings (GUESS, Astria) enable sector roll-up bets in fragmented industries
- Distressed Asset Exits◆
Delisting/control changes (Astria, GUESS) position targets for private equity buyouts or bargains
Sector Themes(3)
- SPAC and Acquisition Frenzy◆
20+ filings from SPAC-like entities (ASPAC III, EGH, Quantumsphere, Spring Valley) entering MDAs signal accelerated de-SPAC cycle, boosting M&A velocity but dilution risks
- Biotech Distress Convergence◆
Delistings and control shifts (KALA BIO, REVIVA, Astria, Aprea) cluster in biopharma, reflecting funding squeezes and consolidation pressures
50+ officer changes (ADI, NVDA, LCID, SQ) across tech/healthcare/banking imply talent reallocation amid economic shifts, potential for activist interventions
Watch List(4)
High-materiality 9/10 delisting/control change combo requires full filing review for takeover details
Bearish 9/10 insolvency update in CoC process amid global priority stream
Cluster of high-materiality 7-8/10 MDAs with undisclosed terms for M&A breakout potential
- Analog Devices (ADI) / NVIDIA (NVDA)👁
Notable tech names in executive churn wave; monitor for strategic shifts
Filing Analyses(108)
23-01-2026
Shirpur Gold Refinery Ltd (512289) informed BSE on January 23, 2026, regarding Corporate Insolvency Resolution Process (CIRP) compliances for the quarter ended December 31, 2025. This is a routine update under ongoing CIRP proceedings. No specific financial details, creditor information, or resolution timelines were disclosed.
23-01-2026
RBI has announced the auction (re-issue) of one Government of India (GoI) dated security on January 23, 2026. The notified amount is not specified in the provided filing. Sectors mentioned: banking, technology.
23-01-2026
SAB Events & Governance Now Media Ltd (BSE: 540081) has issued a post facto intimation regarding the outcome of the 3rd meeting of the Committee of Creditors (CoC) in its ongoing Pre-Packaged Insolvency Resolution Process (PPIRP) under the Corporate Insolvency Resolution Process (CIRP). The announcement dated January 23, 2026, from BSE provides no specific details on meeting outcomes, claims, or resolution plans. No quantitative financial data, creditor details, or timelines are disclosed.
23-01-2026
OneIM Acquisition Corp. filed an 8-K on January 23, 2026 (AccNo: 0001213900-26-006879), announcing a Merger/Acquisition event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on deal structure, parties involved, valuation, transaction type, strategic rationale, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
LanzaTech Global, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003163), reporting multiple items including Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Item 5.03), and Financial Statements and Exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or financial impacts disclosed in the provided summary. Sector is not specified.
23-01-2026
Ocular Therapeutix, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006015, Size: 188 KB) disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. Sector is not specified.
23-01-2026
Analog Devices Inc filed a Form 8-K on January 23, 2026 (AccNo: 0000006281-26-000008, Size: 220 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation status, reasons, or other quantitative data are provided.
23-01-2026
Axogen, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0000805928-26-000026, Size: 655 KB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core event, transaction value, financial impacts, or named entities disclosed in the provided summary. All quantitative data, scheduled events, and further context are NOT_DISCLOSED.
23-01-2026
Datavault AI Inc. filed an 8-K on January 23, 2026 (AccNo: 0001104659-26-006014), disclosing under Item 2.01 the completion of an acquisition or disposition of assets, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on parties involved, deal structure, valuation, consideration, or financial metrics are disclosed. Sector is not specified.
23-01-2026
ETHZilla Corp filed an 8-K on January 23, 2026 (AccNo: 0001213900-26-006924) disclosing under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 provides financial statements and exhibits related to the transaction. No details on parties involved, deal structure, valuation, or strategic rationale are specified.
23-01-2026
Massimo Group filed a Form 8-K on 2026-01-23 (AccNo: 0001493152-26-003318, Size: 201 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any named individuals are provided in the filing summary. Sector is not specified, and no quantitative data, scheduled events, or further governance implications are disclosed.
23-01-2026
NeoVolta Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001683168-26-000482), reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing for Items 1.01 and 2.02, with voluntary Item 7.01. No specific details on the agreement, transaction values, financial metrics, or impacts are disclosed in the provided information.
23-01-2026
Matador Resources Co filed a Form 8-K on 2026-01-23 (AccNo: 0001628280-26-003190, Size: 205 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason, or compensation provided.
23-01-2026
ASPAC III Acquisition Corp. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-006925, Size: 246 KB) under Item 3.02 disclosing unregistered sales of equity securities in connection with a merger/acquisition event. No details on parties involved, deal structure, valuation, consideration, synergies, regulatory pathway, shareholder impact, or sector implications are provided. Sector is not specified.
23-01-2026
Bed Bath & Beyond, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001130713-26-000010, Size: 13 MB), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were filed. No specific details on the officer involved, position affected, nature of change (appointment or resignation), reasons, or any quantitative data are disclosed.
23-01-2026
Acadia Healthcare Company, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001193125-26-020169, Size: 233 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation status, reasons, or individuals involved are disclosed. Sector not specified.
23-01-2026
Lendway, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006044), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, obligation, dollar values, counterparties, or other quantitative data disclosed in the provided summary. Sector is not specified.
23-01-2026
Lake Superior Acquisition Corp filed an 8-K on 2026-01-23 (AccNo: 0001477932-26-000348, Size: 237 KB) announcing a Merger/Acquisition under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific deal structure, parties, valuation, financial metrics, or strategic details are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
GUESS INC filed an 8-K on January 23, 2026 (AccNo: 0001193125-26-020386) disclosing multiple material events including entry into and termination of a material definitive agreement (Items 1.01, 1.02), completion of acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation (Item 2.03), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of registrant (Item 5.01), and changes in directors/officers including compensatory arrangements (Item 5.02). These disclosures suggest a significant corporate transaction such as a merger, acquisition, or going-private event leading to delisting and control change. No specific parties, deal values, or financial metrics are disclosed.
23-01-2026
EGH Acquisition Corp. filed an 8-K on January 23, 2026 (AccNo: 0001104659-26-006046, Size: 2 MB), disclosing under Item 1.01 Entry into a Material Definitive Agreement related to a Merger/Acquisition event, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on parties, structure, valuation, or other deal terms are provided in the filing summary. Sector is not specified.
23-01-2026
QT Imaging Holdings, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003206, Size: 903 KB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction values, parties involved, or financial impacts disclosed in the provided summary. Sector is not specified.
23-01-2026
WesBanco Inc filed an 8-K on January 23, 2026 (AccNo: 0001193125-26-020368), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the summary. Sector is not specified.
23-01-2026
Plumas Bancorp filed an 8-K on 2026-01-23 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). AccNo: 0001437749-26-001817, file size 165 KB. No specific details on the officer position, appointment/resignation, reasons, or compensation provided in the available information.
23-01-2026
NEXTNRG, INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003324, Size: 219 KB), reporting under Item 1.02 the termination of a material definitive agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, dollar values, or financial impacts provided in the summary. Sector not specified.
23-01-2026
BV Financial, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0000943374-26-000014, Size: 296 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, individual names, appointment/resignation status, reasons, or timing are provided in the filing summary. Sector is not specified.
23-01-2026
Company filed Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006102), disclosing Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No details on the specific agreement, transaction terms, parties involved, financial impacts, or exhibits are provided in the excerpt. Analysis is severely limited by absence of filing content beyond item headers.
23-01-2026
C & F FINANCIAL CORP filed an 8-K on 2026-01-23 (AccNo: 0000913341-26-000003, Size: 170 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's name, title, reason for change, or exhibits are provided in the summary. Sector not specified.
23-01-2026
SEC filing dated January 23, 2026 (AccNo: 0001493152-26-003332, Size: 297 KB) discloses a Merger/Acquisition event with Item 1.01 Entry into a Material Definitive Agreement, Item 5.03 Amendments to Articles of Incorporation or Bylaws or Change in Fiscal Year, Item 5.07 Submission of Matters to a Vote of Security Holders, and Item 9.01 Financial Statements and Exhibits. No specific parties, deal structure, valuation, transaction value, share counts, percentages, financial metrics, named entities, or scheduled events are mentioned. All quantitative and qualitative deal details are NOT_DISCLOSED.
23-01-2026
Planet Labs PBC filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-020587), reporting Item 3.02 (Unregistered Sales of Equity Securities), Item 3.03 (Material Modifications to Rights of Security Holders), and Item 8.01 (Other Events). This is a multi-item filing with no specific transaction details, dollar values, share counts, or financial metrics disclosed. Core events involve equity securities sales and rights modifications, but all quantitative data is NOT_DISCLOSED.
23-01-2026
Company filed an 8-K on 2026-01-23 (AccNo: 0001829126-26-000478, Size: 188 KB) under Item 5.02 disclosing an officer change event dated January 23, 2026. Event type is Officer Change related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on officer name, position, appointment/resignation, reasons, or impacts are disclosed in the provided filing summary.
23-01-2026
Westamerica Bancorporation filed an 8-K on 2026-01-23 (AccNo: 0001171843-26-000400, Size: 187 KB) disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or quantitative data are provided in the filing summary. Event classified as Officer Change; sector not specified.
23-01-2026
Unidentified company filed an 8-K on 2026-01-23 (AccNo: 0001213900-26-007067, Size: 268 KB) under Items 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), signaling an officer change event dated January 23, 2026. No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or departure, reasons, named individuals, or quantitative data are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
BJ's Restaurants Inc. filed an 8-K on January 23, 2026 (AccNo: 0001193125-26-020736, Size: 207 KB) disclosing an Item 5.02 event involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are provided in the available information. Sector not specified.
23-01-2026
The company filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-020910, Size: 2 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing as Item 1.01 triggers required disclosure within 4 business days. No specific details on the agreement, events, transaction value, parties, or financial impacts are disclosed in the provided filing summary.
23-01-2026
The company filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006207, Size: 3 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item material event disclosure with no specific details provided on the agreement, events, transaction value, or financial impacts. Sector is not specified.
23-01-2026
Company filed 8-K on 2026-01-23 (AccNo: 0001193125-26-020905) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 2.03 Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement. Item 9.01 discloses Financial Statements and Exhibits. No specific transaction details, values, parties, or terms provided.
23-01-2026
Company filed Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006208, Size: 2 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing classified as a Material Event, but specific details of the agreement, events, or exhibits are NOT_DISCLOSED. No quantitative data, named entities, or scheduled events are mentioned.
23-01-2026
FG Imperii Acquisition Corp. filed an 8-K on January 23, 2026 (AccNo: 0001104659-26-006213), disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific parties, deal structure, valuation, synergies, or quantitative terms are disclosed in the provided filing summary. Sector not specified.
23-01-2026
The company filed an 8-K on 2026-01-23 (AccNo: 0001829126-26-000489, Size: 187 KB) under Item 5.02 disclosing an officer change event dated January 23, 2026. No specific details provided on the officer's name, position (e.g., CEO, CFO), nature of change (appointment, resignation, or compensatory arrangement), reason, or any quantitative data. Sector not specified.
23-01-2026
YUNHONG GREEN CTI LTD. filed a Form 8-K on 2026-01-23 (AccNo: 0001493152-26-003370, Size: 196 KB) disclosing an event under Item 5.02. The item covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on individuals, positions, reasons, or arrangements are explicitly stated.
23-01-2026
Bleichroeder Acquisition Corp. II filed an 8-K on January 23, 2026 (AccNo: 0001213900-26-007203, Size: 261 KB) announcing a Merger/Acquisition event under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties involved, valuation, strategic rationale, or quantitative metrics such as transaction value, share counts, or percentages are disclosed. Sector is not specified.
23-01-2026
VisionWave Holdings, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001731122-26-000106, Size: 644 KB) reporting a Material Event under Item 1.01 for Entry into a Material Definitive Agreement and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing with no specific details provided on the agreement, transaction terms, parties involved, or financial impacts. Sector is not specified.
23-01-2026
ZYNEX INC filed a Form 8-K on 2026-01-23 (AccNo: 0001104659-26-006240) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.
23-01-2026
LightPath Technologies Inc filed an 8-K on 2026-01-23 (AccNo: 0001437749-26-001904, Size: 1 MB) disclosing a merger/acquisition event with Item 1.01 (Entry into Material Definitive Agreement), Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 2.03 (Creation of Direct Financial Obligation), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Specific details including parties involved, deal structure, valuation, transaction type, strategic rationale, and quantitative metrics are NOT_DISCLOSED. Sector not specified.
23-01-2026
Ondas Holdings Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007197), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or quantitative impacts disclosed in the provided information. Sector not specified.
23-01-2026
International Paper Co (/NEW/) filed an 8-K on January 23, 2026 (AccNo: 0001628280-26-003279), disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing also includes Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on parties involved, deal structure, valuation, target, or financial metrics are mentioned.
23-01-2026
Quantumsphere Acquisition Corp, a SPAC-like entity, filed an 8-K on 2026-01-23 (AccNo: 0001829126-26-000503, Size: 298 KB) disclosing Item 1.01 Entry into a Material Definitive Agreement related to a Merger/Acquisition event and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties involved, valuation, consideration type, strategic rationale, regulatory pathway, shareholder impact, or quantitative metrics such as transaction value, share counts, or percentages are disclosed in the provided filing summary. Sector not specified; analysis limited to filing items only.
23-01-2026
XCel Brands, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006234), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided summary. Sector is not specified.
23-01-2026
Block, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021035, Size: 137 KB) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer involved, position affected, nature of change (appointment or resignation), reasons, or quantitative data are provided. Sector is not specified, and no scheduled events or financial metrics are mentioned.
23-01-2026
SharonAI Holdings, Inc. filed Form 8-K on 2026-01-23 (AccNo: 0001829126-26-000505, Size: 765 KB) reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), departure/election/appointment of directors or certain officers including compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing covering material events. No specific transaction details, values, names, or financial metrics are disclosed.
23-01-2026
Barfresh Food Group Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003375, Size: 198 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, appointment/resignation status, reasons, or compensation are provided in the summary. Sector is not specified.
23-01-2026
Jones Soda Co filed a Form 8-K on 2026-01-23 (AccNo: 0001493152-26-003378, size: 196 KB) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 1.02 Termination of a Material Definitive Agreement. This is a multi-item filing with no details provided on the agreements, parties, transaction values, or financial impacts. Sector not specified.
23-01-2026
KALA BIO, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001829126-26-000502) under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. No additional details on the delisting reason, financial impacts, or transaction values are provided in the available information. Sector not specified.
23-01-2026
Astria Therapeutics, Inc. filed an 8-K on January 23, 2026 (AccNo: 0001104659-26-006228, Size: 353 KB), disclosing entry into a material definitive agreement (Item 1.01), completion of acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation (Item 2.03), notice of delisting (Item 3.01), material modifications to security holders' rights (Item 3.03), changes in control (Item 5.01), director/officer changes (Item 5.02), amendments to articles/bylaws (Item 5.03), and financial statements (Item 9.01). This indicates a significant merger/acquisition event for the company, likely positioning Astria as the target given delisting and control change triggers. No specific parties, deal structure, valuation, or financial metrics are disclosed.
23-01-2026
Lucid Group, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001628280-26-003278, Size: 159 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.
23-01-2026
Blue Owl Technology Finance Corp. filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003277, Size: 755 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, events, transaction values, or financial impacts are disclosed in the provided filing summary. Sector not specified.
23-01-2026
AAR CORP filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006227, Size: 250 KB) under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data are provided in the available information. Sector is not specified.
23-01-2026
Two Hands Corp filed a Form 8-K on January 23, 2026 (AccNo: 0001494413-26-000004, Size: 5 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing as a material event. No transaction details, dollar values, or other quantitative data disclosed.
23-01-2026
Abpro Holdings, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007215), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, named parties, or quantitative impacts disclosed. Sector not specified.
23-01-2026
Marpai, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001213900-26-007191, Size: 191 KB) disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, compensation, or other quantitative data are provided in the summary. Sector is not specified.
23-01-2026
Health Catalyst, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001636422-26-000010, Size: 170 KB) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer involved, nature of change (appointment or resignation), reasons, or compensation are provided in the summary. Sector is not specified.
23-01-2026
Bluerock Acquisition Corp. filed an 8-K on 2026-01-23 (AccNo: 0001213900-26-007216, Size: 304 KB) disclosing Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers, and Item 9.01: Financial Statements and Exhibits. No merger, acquisition, transaction details, parties, valuations, or quantitative data are mentioned. Sector not specified.
23-01-2026
NexPoint Real Estate Finance, Inc. filed an 8-K on 2026-01-23 (AccNo: 0001437749-26-001916, Size: 177 KB) reporting Item 1.01: Entry into a Material Definitive Agreement. No details on the agreement's parties, terms, value, or financial impact are provided in the summary. Sector not specified.
23-01-2026
Jaguar Health, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001193125-26-021064) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, share counts, or other numerical data disclosed in the provided summary. All core event details such as agreement terms, parties, or financial impacts are NOT_DISCLOSED.
23-01-2026
Elme Communities filed a Form 8-K on January 23, 2026 (AccNo: 0000104894-26-000004, Size: 530 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or any quantitative data are provided in the filing summary. Sector not specified.
23-01-2026
JFB Construction Holdings filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003384, Size: 327 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer position, appointment/resignation, reasons, or compensation are provided.
23-01-2026
RXO, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0000950142-26-000221, Size: 187 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the available information. Sector is not specified.
23-01-2026
REVIVA PHARMACEUTICALS HOLDINGS, INC. filed an 8-K on 2026-01-23 (AccNo: 0001437749-26-001913, size 179 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, and under Item 8.01 Other Events. This indicates a delisting event from the US market, but no further details on reasons, financial impacts, or transaction values are disclosed.
23-01-2026
Company filed Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021081), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event, but specific details on the agreement, obligation, transaction value, parties, or exhibits are NOT_DISCLOSED in the provided information. No quantitative data, named entities, or scheduled events are mentioned.
23-01-2026
Jabil Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021086, Size: 582 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, transaction value, or financial impacts disclosed in the provided summary. Sector not specified.
23-01-2026
Six Flags Entertainment Corporation filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021051, Size: 150 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, or financial impacts disclosed in the provided information. Sector is not specified.
23-01-2026
Ryder System Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003301, Size: 140 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer's name, position, appointment/resignation status, reasons, or quantitative data are provided.
23-01-2026
Cerus Corp (CERUS) filed an 8-K on January 23, 2026 (AccNo: 0001193125-26-021085, Size: 141 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment/resignation status, reasons, or timing are provided. Sector is not specified.
23-01-2026
Biocryst Pharmaceuticals Inc filed a Form 8-K on January 23, 2026 (AccNo: 0001171843-26-000405, Size: 189 KB), disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or compensatory terms are stated. Sector not specified.
23-01-2026
GAXOS.AI INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007257, Size: 492 KB) reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided summary. Sector not specified.
23-01-2026
Company filed an 8-K on 2026-01-23 (AccNo: 0001493152-26-003419, Size: 199 KB) under Item 5.02 disclosing an officer change event dated January 23, 2026. Event type is specified as 'Officer Change' with no further details on position, individual, appointment/resignation, or reasons provided. Sector not specified; no quantitative data, named entities, or scheduled events mentioned.
23-01-2026
Trailblazer Merger Corp I, a likely SPAC, filed an 8-K on 2026-01-23 (AccNo: 0001213900-26-007230, Size: 256 KB) under Item 5.02 disclosing departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No details on any merger/acquisition, parties, valuation, or strategic rationale are mentioned. Sector not specified.
23-01-2026
ProCap Financial, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003410, Size: 256 KB) disclosing an officer change under Item 5.02. Item 5.02 covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the officer, position, reason for change, or other impacts are provided; sector is not specified.
23-01-2026
Collab Z Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007244, Size: 601 KB), reporting multiple items: 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction values, parties involved, or financial impacts provided in the summary. Sector is not specified.
23-01-2026
INNO HOLDINGS INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003411, Size: 462 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties involved, financial impacts, or strategic rationale are disclosed in the provided information. Sector is not specified.
23-01-2026
NEW JERSEY RESOURCES CORP filed a Form 8-K on January 23, 2026 (AccNo: 0001140361-26-002201, Size: 176 KB), reporting under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). No specific details on officer changes, voting outcomes, or exhibits are disclosed in the provided summary. Event classified as Officer Change from US SEC source.
23-01-2026
BIOCRYST PHARMACEUTICALS INC filed an 8-K on 2026-01-23 (AccNo: 0001140361-26-002200, Size: 2 MB) disclosing a Merger/Acquisition event with Item 1.01 (Entry into a Material Definitive Agreement), Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on parties involved, deal structure, valuation, or quantitative metrics are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
Bain Capital Specialty Finance, Inc. filed an 8-K on January 23, 2026 (AccNo: 0001193125-26-021189), reporting entry into a Material Definitive Agreement under Item 1.01 and including Financial Statements and Exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction value, or financial impacts disclosed in the provided information. Sector not specified.
23-01-2026
Cathay General Bancorp filed a Form 8-K on January 23, 2026 (AccNo: 0001437749-26-001931), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED in the provided filing summary. No quantitative data, scheduled events, or financial metrics are mentioned.
23-01-2026
Primerica, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021183, Size: 206 KB) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the summary. Sector is not specified.
23-01-2026
Chain Bridge Bancorp Inc filed an 8-K on January 23, 2026 (AccNo: 0001628280-26-003313, Size: 144 KB) disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on the affected officers, reasons for change, or compensatory terms are provided in the available information. Sector is not specified.
23-01-2026
Aprea Therapeutics, Inc. filed a Form 8-K on 2026-01-23 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No specific reasons, financial impacts, transaction values, or other details are disclosed in the provided summary. Filing Accession Number: 0001104659-26-006267, size: 191 KB.
23-01-2026
374Water Inc. disclosed an officer change via SEC Form 8-K filed on January 23, 2026 (AccNo: 0001654954-26-000569, Size: 136 KB). The filing pertains to Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons, or quantitative data are disclosed in the provided filing summary.
23-01-2026
NU RIDE INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003436, Size: 190 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 8.01 Other Events. No details on the agreement, transaction size, or events are disclosed in the provided summary. Sector is not specified.
23-01-2026
Form 8-K filed January 23, 2026 (AccNo: 0000929638-26-000243, Size: 3 MB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item Material Event filing from an unspecified company and sector. No details on the agreement, events, transaction value, or exhibits are disclosed.
23-01-2026
Pacific Oak Strategic Opportunity REIT, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001452936-26-000007, Size: 155 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. This is a multi-item filing with no specific transaction values, names, or financial details disclosed in the summary. Sector is not specified.
23-01-2026
This Form 8-K filing under Item 4.01 reports changes in the registrant's certifying accountant, filed on January 23, 2026, with Accession Number 0001213900-26-007298 and file size 184 KB. No merger or acquisition details, parties, valuations, or strategic rationale are disclosed. Sector is not specified.
23-01-2026
Matinas BioPharma Holdings, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003445, Size: 209 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or quantitative data are provided in the filing summary. Sector is not specified.
23-01-2026
Q/C TECHNOLOGIES, INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003440), reporting a multi-item disclosure under Items 1.01 (Entry into a Material Definitive Agreement), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the agreement, personnel changes, events, transaction values, financial metrics, or named entities are disclosed in the provided summary. All quantitative data, dollar values, share counts, and scheduled events are NOT_DISCLOSED.
23-01-2026
Nuwellis, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001140361-26-002241, Size: 201 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, or any quantitative data are explicitly stated. Event type is Officer Change; sector not specified.
23-01-2026
NVIDIA Corp disclosed an officer change via Form 8-K filed on January 23, 2026 (AccNo: 0001045810-26-000003, Size: 133 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons, or quantitative data are provided in the filing summary. Sector is not specified.
23-01-2026
Conduent Inc filed a Form 8-K on January 23, 2026 (AccNo: 0001140361-26-002237), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer's name, title (e.g., CEO, CFO), appointment/resignation status, reasons, or timing are disclosed in the provided information. No quantitative data, named individuals, or scheduled events are mentioned.
23-01-2026
Modular Medical, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001213900-26-007296, Size: 1 MB) reporting under Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 5.07 (Submission of Matters to a Vote of Security Holders), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific event details, transaction values, or numerical data disclosed in the summary. Sector not specified.
23-01-2026
Teleflex Inc. disclosed an officer change via Form 8-K filed on January 23, 2026 (AccNo: 0000096943-26-000006, Size: 141 KB) under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, appointment or resignation, reasons, or quantitative data are provided in the filing summary. Sector is not specified.
23-01-2026
QHSLab, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003438), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or financial metrics disclosed in the provided information. Sector is not specified.
23-01-2026
Spring Valley Acquisition Corp. III filed an 8-K on January 23, 2026 (AccNo: 0001104659-26-006283), disclosing under Item 1.01 entry into a Material Definitive Agreement related to a Merger/Acquisition event. Item 3.02 covers Unregistered Sales of Equity Securities, and Item 9.01 provides Financial Statements and Exhibits. No specific details on parties, deal structure, valuation, or quantitative metrics are disclosed.
23-01-2026
Soleno Therapeutics Inc filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-021229, Size: 298 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the filing summary. Sector is not specified.
23-01-2026
KB Home filed a Form 8-K on January 23, 2026 (AccNo: 0000795266-26-000019, Size: 186 KB), disclosing Item 5.02 regarding the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for changes, or quantitative data are provided in the available information. Sector is not specified.
23-01-2026
ProPhase Labs, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003456, Size: 893 KB), reporting a multi-item disclosure under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). No details on the core transaction, parties, dollar value, share counts, or financial impacts are explicitly stated in the provided filing summary. This is a mandatory disclosure triggered by material events.
23-01-2026
Company filed Form 8-K on 2026-01-23 (AccNo: 0000921825-26-000003) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Obligation under an Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing classified as a Material Event. No specific details on the core event, transaction value, parties, financial impacts, or scheduled events are disclosed.
23-01-2026
Nexalin Technology, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001829126-26-000513, Size: 255 KB), reporting under Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This indicates a delisting event from the US market. No specific details on delisting reasons, financial impacts, transaction values, or other quantitative data are disclosed in the provided information.
23-01-2026
TLGY Acquisition Corp filed an 8-K on January 23, 2026 (AccNo: 0001213900-26-007343), disclosing under Item 1.01 entry into a Material Definitive Agreement, indicative of a merger or acquisition event. Item 9.01 covers Financial Statements and Exhibits. No specific details on parties, deal structure, valuation, or sector provided.
23-01-2026
60 Degrees Pharmaceuticals, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-007330, Size: 240 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, indicating delisting from the US market. Item 7.01 covers Regulation FD Disclosure. No quantitative data, financial impacts, or specific reasons for delisting are disclosed in the provided information.
Get daily alerts with 5 investment signals, 4 risk alerts, 3 opportunities and full AI analysis of all 108 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC